Sep 17, 2021 09:28AM Pre-Open Stock Movers 09/17: (CRVS) (ABCL) (BGNE) Higher; (PTGX) (GRTS) (X) Lower (more...)

Dec 15, 2020 04:30PM Protagonist Therapeutics, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Dec 11, 2020 06:06AM Protagonist Therapeutics (PTGX) Prices 4.76M Share Common Offering at $21/Sh

Dec 10, 2020 11:10PM Protagonist Therapeutics, Inc. Announces Pricing of $100 Million Public Offering of Common Stock

Dec 10, 2020 07:30AM Protagonist Therapeutics (PTGX) Announces $100M Proposed Public Offering of Common Stock

Dec 10, 2020 07:30AM Protagonist Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

May 12, 2020 12:57AM Protagonist Therapeutics, Inc. Announces Upsizing and Pricing of Underwritten Public Offering of 7,000,000 Shares of Common Stock

May 11, 2020 07:00AM Protagonist Therapeutics (PTGX) Announces Proposed 5M Share Underwritten Public Offering of Common Stock

May 11, 2020 06:59AM Protagonist Therapeutics, Inc. Announces Proposed Underwritten Public Offering of Common Stock

Feb 21, 2019 05:05PM BMO Capital Starts Protagonist Therapeutics (PTGX) at Outperform

Dec 5, 2018 07:00AM Protagonist Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

Mar 26, 2018 10:22AM Protagonist Therapeutics (PTGX) PT Lowered to $13 at BMO Capital

Mar 8, 2018 05:47AM Protagonist Therapeutics (PTGX) PT Trimmed to $42 at BMO Capital, But Sees Catalyst-Rich 2018

Dec 4, 2017 08:00AM Protagonist Therapeutics to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

Oct 12, 2017 05:45AM Protagonist Therapeutics (PTGX) Prices 3.53M Share Common Offering at $17/Sh

Oct 11, 2017 10:26PM Protagonist Therapeutics Prices Public Offering of Common Stock

Oct 11, 2017 04:03PM Protagonist Therapeutics (PTGX) Announces Proposed Common Share Offering

Oct 11, 2017 04:01PM Protagonist Therapeutics Announces Proposed Public Offering of Common Stock

May 30, 2017 01:40PM Protagonist Therapeutics (PTGX) PT Raised to $45 at BMO Capital on Janssen Deal; Sees 447% Upside

Nov 15, 2016 08:55AM Protagonist Therapeutics (PTGX) PT Raised to $34 at BMO Capital; Increased Confidence in PTG-100

Sep 6, 2016 06:37AM BMO Capital Starts Protagonist Therapeutics (PTGX) at Outperform

Aug 11, 2016 11:29AM Protagonist Therapeutics (PTGX) IPO Opened Flat

Aug 11, 2016 08:58AM UPDATE: Protagonist Therapeutics (PTGX) Prices 7.5M Common Stock IPO at $12/Share, Flat with Expectations

Aug 10, 2016 10:47PM Protagonist Therapeutics Announces Pricing of Initial Public Offering

Jul 11, 2016 05:18PM Protagonist Therapeutics (PTGX) Files $75M IPO